What are the trends in the treatment of multiple sclerosis in recent studies? – A bibliometric analysis with global productivity during 1980–2021

医学 多发性硬化 格拉默 芬戈莫德 主题(文档) 生产力 文献计量学 家庭医学 图书馆学 精神科 计算机科学 宏观经济学 经济
作者
Serdar Aykaç,Sinan Eliaçık
出处
期刊:Multiple sclerosis and related disorders [Elsevier BV]
卷期号:68: 104185-104185 被引量:14
标识
DOI:10.1016/j.msard.2022.104185
摘要

There is no bibliometric analysis in the literature on the subject of the treatment of multiple sclerosis (MS), which is a disease with increasing prevalence, severely affecting the life and quality of life of patients. The purpose of this study was to analyze the scientific articles published on the subject of MS treatment, using bibliometric approaches and statistical methods, and thereby show the trend subjects and global productivity.From 14,443 publications on the subject of MS between 1980 and 2021, 5010 in the category of article were retrieved from the Web of Science and analyzed statistically. Bibliometric network visualization diagrams were created to determine trend subjects, collaborations between countries and citation analyzes. Exponential Smoothing estimation was used to predict the number of articles to be published in the next 5 years. Correlations were determined using Spearman's correlation analysis.The 3 countries contributing the most to literature were found to be the USA (1385, 37.6%), Italy (700, 13.9%), and Germany (694, 13.8%). The most productive author was Hartung Hans-Peter (n = 82) and the most productive institution was the University of London (n = 198). The three most productive journals were the Multiple Sclerosis Journal (n = 354), Multiple Sclerosis and Related Disorders (n = 224), and Neurology (n = 204). The most studied subjects can be listed from past to present as interferon beta, disease-modifying treatment or drugs, relapsing, natalizumab, fingolimod, glatiramer acetate, fatigue, alemtuzumab, cytokines, mitoxantrone, MRI, adherence, depression, experimental autoimmune encephalomyelitis, quality of life, and biomarkers.The scientific production related to MS treatment shows growth chronologically over the years. According to the findings of the analysis done to identify trending subjects, the key words studied in recent years were determined to be fingolimod, alemtuzumab, disease-modifying therapy, ocrelizumab, teriflunomide, rituximab, dimethyl fumarate, safety, biomarkers, COVID-19, oxidative stress, inflammation, vitamin D, relapsing multiple sclerosis, cost-effectiveness, cladribine tablets, and medication adherence. Western countries, especially European countries, the USA, and Canada lead the way in research and scientific collaboration on the subject of MS treatment. These findings can contribute to a better understanding of this subject and can help provide new ideas for further studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
skf完成签到,获得积分10
刚刚
bkagyin应助战战采纳,获得10
刚刚
齐半青完成签到,获得积分10
1秒前
1秒前
阿斯顿发布了新的文献求助10
1秒前
billevans完成签到,获得积分10
2秒前
XHH1994完成签到,获得积分10
2秒前
张火火发布了新的文献求助20
2秒前
爆米花应助DYQin采纳,获得10
2秒前
mingyahaoa完成签到,获得积分10
2秒前
机灵的白筠完成签到,获得积分20
2秒前
CipherSage应助燕子采纳,获得30
2秒前
Accpted河豚发布了新的文献求助10
2秒前
BenLuo发布了新的文献求助30
3秒前
云歇雨住发布了新的文献求助10
3秒前
Oak完成签到 ,获得积分10
3秒前
量子星尘发布了新的文献求助10
3秒前
chen完成签到,获得积分10
3秒前
4秒前
4秒前
4秒前
4秒前
4秒前
5秒前
光_sun完成签到,获得积分10
5秒前
腦內小劇場完成签到,获得积分10
5秒前
无花果应助徐xmr采纳,获得10
5秒前
5秒前
木木酱完成签到,获得积分10
6秒前
yuajianhei完成签到,获得积分10
6秒前
CNAxiaozhu7完成签到,获得积分10
6秒前
莫三颜发布了新的文献求助10
6秒前
6秒前
敢甘完成签到,获得积分10
6秒前
qqj发布了新的文献求助80
7秒前
DD发布了新的文献求助10
7秒前
微笑完成签到,获得积分10
8秒前
real_cy完成签到,获得积分10
8秒前
8秒前
8秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969060
求助须知:如何正确求助?哪些是违规求助? 3513962
关于积分的说明 11171223
捐赠科研通 3249302
什么是DOI,文献DOI怎么找? 1794772
邀请新用户注册赠送积分活动 875377
科研通“疑难数据库(出版商)”最低求助积分说明 804769